InflaRx

$4.29
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.03 (+0.76%) Today
+$0.31 (+7.79%) As of 5:00 PM EST after-hours

Why Robinhood?

You can buy or sell InflaRx and other stocks, options, and ETFs commission-free!

About IFRX

InflaRx N.V. Common Stock, also called InflaRx, is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a. Its products include IFX-1 and IFX-2. The company was founded by Niels Christoph Riedemann, Renfeng Guo and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany. The listed name for IFRX is InflaRx N.V. Common Stock.

CEO
Niels Christoph Riedemann
Employees
45
Headquarters
Jena, Thueringen
Founded
2007
Market Cap
103.90M
Price-Earnings Ratio
Dividend Yield
Average Volume
173.06K
High Today
$4.12
Low Today
$3.90
Open Price
$3.98
Volume
188.47K
52 Week High
$9.70
52 Week Low
$2.52

Collections

IFRX Earnings

-$0.65
-$0.43
-$0.22
$0.00
Q4 FY18
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
per share
Actual
-$0.29 per share

You May Also Like